Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
NeoplasmsThis is a prospective study for the long-term follow-up (LTFU) of safety and efficacy for all pediatric and adult participants exposed to Gene-modified (GM) T cell therapy participating in a previous Celgene sponsored or Celgene alliance partner sponsored study.
Participants who received at least one GM T cell infusion will be asked to enroll in this LTFU protocol upon either premature discontinuation from, or completion of the prior parent treatment protocol.
null
Conditions de participation
-
Sexe:
ALL -
Âges admissibles:
0 and up
Critères de participation
Inclusion Criteria:
* Received at least one gene-modified (GM) T-cell infusion in a previous Celgene sponsored or Celgene alliance partner-sponsored study, and have discontinued, or completed the post-treatment follow-up period in the parent treatment protocol, as applicable.
* Must understand and voluntarily sign an Informed Consent Form/Informed Assent Form prior to any study-related assessments/procedures being conducted.
Exclusion Criteria:
Not Applicable
Other protocol-defined inclusion/exclusion criteria apply
Lieu de l'étude
Local Institution - 02801
Local Institution - 02801Hamilton, Ontario
Canada
Contactez l'équipe d'étude
Local Institution - 02802
Local Institution - 02802Vancouver, British Columbia
Canada
Contactez l'équipe d'étude
Princess Margaret Cancer Centre
Princess Margaret Cancer CentreToronto, Ontario
Canada
Contactez l'équipe d'étude
Christine Chen, Site 02301
4169464501University Of Calgary
University Of CalgaryCalgary, Alberta
Canada
Contactez l'équipe d'étude
Nizar Bahlis, Site 02302
4039441880CIUSSS de l'Est-de-l'Ile-de-Montreal
CIUSSS de l'Est-de-l'Ile-de-MontrealMontreal, Quebec
Canada
Contactez l'équipe d'étude
Isabelle Fleury, Site 02800
5142523404- Étude parrainée par
- Celgene
- Participants recherchés
- Plus d'informations
- ID de l'étude:
NCT03435796